Literature DB >> 23909491

Effects of OPRM1 A118G polymorphism on epidural analgesia with fentanyl during labor: a meta-analysis.

Zheming Song1, Boxiang Du, Kai Wang, Xueyin Shi.   

Abstract

BACKGROUND: Emerging evidence has shown that the most common polymorphism (A118G; rs1799971 A>G) in the μ-opioid receptor (OPRM1) gene may influence the response to labor analgesia, but individually published studies showed inconclusive results.
OBJECTIVE: This meta-analysis aimed to derive a more precise estimation of the effects of the OPRM1 A118G polymorphism on epidural analgesia with fentanyl during labor.
METHODS: A literature search was conducted on PubMed, Embase, Web of Science, and China BioMedicine databases before April 1st, 2013. The crude standardized mean difference (SMD) or odds ratio (OR) with 95% confidence interval (CI) was calculated.
RESULTS: Six clinical studies were included with a total 838 women who received epidural analgesia with fentanyl during labor. The meta-analysis results indicated that women carrying the G allele (AG+GG) of the OPRM1 A118G polymorphism required less fentanyl doses to achieve adequate pain relief compared with those with the AA homozygote (SMD=-0.24, 95% CI [-0.44, -0.03], p=0.022). The 118G variant was associated with a decreased ED50 of fentanyl for labor analgesia (SMD=-1.56, 95% CI [-1.97, -1.15], p<0.001). The analgesia satisfaction in women carrying the G allele (AG+GG) was higher than those with the AA homozygote (SMD=0.22, 95% CI [0.05, 0.39], p=0.012). However, there were no statistically significant differences between an AA homozygote and a G carrier (AG+GG) in the incidence of nausea and vomiting (OR=1.99, 95% CI [0.88, 4.52], p=0.101).
CONCLUSION: In conclusion, the current meta-analysis indicates that women carrying the G allele (AG+GG) of OPRM1 A118G polymorphism may have a good response to epidural analgesia with fentanyl during labor. The OPRM1 A118G polymorphism may help predict individuals' response to epidural labor analgesia and so optimize postoperative pain control.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23909491     DOI: 10.1089/gtmb.2013.0282

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  7 in total

1.  Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.

Authors:  Caroline A Browne; Rebecca L Erickson; Julie A Blendy; Irwin Lucki
Journal:  Neuropharmacology       Date:  2017-02-07       Impact factor: 5.250

2.  Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro.

Authors:  Alisa Knapman; Marina Santiago; Mark Connor
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

Review 3.  Genetic factors associated with pharmacotherapy and background sensitivity to postoperative and chemotherapy-induced nausea and vomiting.

Authors:  Piotr K Janicki; Shigekazu Sugino
Journal:  Exp Brain Res       Date:  2014-05-04       Impact factor: 1.972

4.  Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents.

Authors:  V Chidambaran; J Mavi; H Esslinger; V Pilipenko; L J Martin; K Zhang; S Sadhasivam
Journal:  Pharmacogenomics J       Date:  2014-09-30       Impact factor: 3.550

5.  Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice.

Authors:  Yong Zhang; Roberto Picetti; Eduardo R Butelman; Ann Ho; Julie A Blendy; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

6.  Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia.

Authors:  Laura R Lander; Vincent Setola; Shane W Kaski; Stephan Brooks; Sijin Wen; Marc W Haut; David P Siderovski; James H Berry
Journal:  J Opioid Manag       Date:  2019 Mar-Apr

7.  Effects of OPRM1 and ABCB1 gene polymorphisms on the analgesic effect and dose of sufentanil after thoracoscopic-assisted radical resection of lung cancer.

Authors:  Zhonghai Zhao; Bin Lv; Xiaodong Zhao; Yunlong Zhang
Journal:  Biosci Rep       Date:  2019-01-03       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.